First-of-its-kind line of vaccines leverages state-of-the-art RNA-particle technology to protect cats and dogs from rabies RAHWAY, N.J., June 17, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the launch and availability of the NOBIVAC® NXT Rabies portfolio – consisting of NOBIVAC® NXT Feline-3 Rabies and […]
Rahway, N.J., June 4, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the presentation of more than 30 studies at the 27th International Pig Veterinary Society Congress (IVPS) and 15th European Symposium of Porcine Health Management (ESPHM), highlighting new research across the company’s broad swine […]
First centrally registered vaccine in the European Union against the currently circulating avian influenza virus strains of clade 2.3.4.4b RAHWAY, N.J., May 24, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Commission has granted the marketing authorization for the INNOVAX®-ND-H5 vaccine for […]
Data Presented at the World Buiatrics Congress 2024 RAHWAY, N.J., May 21, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced findings on the global economic impact of parasites in cattle, concluding that parasite management is critical for farmers to produce enough beef to meet world […]
Rahway, NJ, May 13, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it will showcase its portfolio of innovative solutions to advance the ruminant health at the World Buiatrics Congress 2024, May 20-24 in Cancun, Mexico. The company will present data from 80 presentations including […]
If approved by the European Commission, the vaccine will become an available tool for governments to consider as part of a holistic strategy to combat the spread of highly pathogenic avian influenza (HPAI) which may include additional vaccinations plus enhanced biosecurity and surveillance Potentially the first centrally registered vaccine in the European Union against the […]
Award to Recognize Three Cutting-Edge Organizations, Startups or Individuals who Promote a Positive Change in the Swine Industry Award Accepting Nominations Through June 30, 2024 RAHWAY, N.J., April 5, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that it is now accepting nominations for the […]
Rahway, NJ., March 18, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK) has announced a continued commitment to rabies elimination through a donation of NOBIVAC® rabies vaccines to the Mission Rabies program, a charity initiative of the Worldwide Veterinary Service (WVS). The donations will continue over the […]
BRAVECTO eliminated kennel infestations of brown dog ticks (Rhipicephalus sanguineus sensu lato) External imidacloprid/flumethrin collar treatments failed to eliminate all ticks from kennels RAHWAY, N.J., March 15, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the publication of a recent study demonstrating the efficacy of […]
RAHWAY, N.J., March 14, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) issued a positive opinion for the NOBILIS MULTRIVA™ RT+IBm+ND+Gm+REOm+EDS vaccine to be administered intramuscularly in chickens from eight weeks of age, to […]